The Total number of records shown on this page is 100. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_2956	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	STS26T	1.0E+4 cells per well	NA	Cell titer assay	0.1 MOI	80% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2957	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	STS26T	1.0E+4 cells per well	NA	Cell titer assay	1 MOI	30% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2958	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	STS26T	1.0E+4 cells per well	NA	Cell titer assay	10 MOI	100% cell death after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2959	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	STS26T	1.0E+4 cells per well	NA	Cell titer assay	0.01 MOI	90% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2960	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	STS26T	1.0E+4 cells per well	NA	Cell titer assay	0.1 MOI	60% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2961	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	STS26T	1.0E+4 cells per well	NA	Cell titer assay	1 MOI	100% cell death after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2962	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	STS26T	1.0E+4 cells per well	NA	Cell titer assay	10 MOI	100% cell death after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2963	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	ST88-14	1.0E+4 cells per well	NA	Cell titer assay	0.01 MOI	90% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2964	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	ST88-14	1.0E+4 cells per well	NA	Cell titer assay	0.1 MOI	70% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2965	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	ST88-14	1.0E+4 cells per well	NA	Cell titer assay	1 MOI	10% cell death after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2966	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	ST88-14	1.0E+4 cells per well	NA	Cell titer assay	10 MOI	100% cell death after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2967	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	HSCIL-1	1.0E+4 cells per well	NA	Cell titer assay	0.01 MOI	90% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2968	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	HSCIL-1	1.0E+4 cells per well	NA	Cell titer assay	0.1 MOI	90% cell survival after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2969	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	HSCIL-1	1.0E+4 cells per well	NA	Cell titer assay	1 MOI	50% cell death after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2970	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	HSCIL-1	1.0E+4 cells per well	NA	Cell titer assay	10 MOI	10% cell death after 72 hours	No	No	NA	No response	NA	NA	NA	NA	25843626
OV_2971	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	NA	Human malignant peripheral nerve sheath tumor cell line	S462TY	NA	NA	NA	NA	NA	Nude Foxn1 mice xenograft for S462TY (5.0E+6)	3.8E+8 TCID	NA	Reduction in tumor volume after 20 days and increase in survival time 49 days	Intratumoral	NA	NA	NA	25843626
OV_3006	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.01 MOI	100% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3007	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	90% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3008	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	80% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3009	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	3 MOI	75% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3010	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	10 MOI	20% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3011	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.01 MOI	100% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3012	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	75% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3013	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	1 MOI	50% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3014	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	3 MOI	30% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3015	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	MTT assay	10 MOI	5% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3016	Measles virus	wild type	RNA	Paramyxoviridae	None	No	CPT (10nM) drug administered first and then virus	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.20 fraction of cell affected, shows antagonism (CI = 1.34)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3017	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus added first and then drug CPT drug administered (10nM)	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.19 fraction of cell affected, shows antagonism (CI = 1.66)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3018	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus and drug (10nM) co-administered	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.56 fraction of cell affected, shows synergism (CI = 0.11)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3019	Measles virus	wild type	RNA	Paramyxoviridae	None	No	CPT (30nM) drug administered first and then virus	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.25 fraction of cell affected, shows antagonism (CI = 1.75)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3020	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus added first and then drug CPT drug administered (30nM)	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.19 fraction of cell affected, shows antagonism (CI = 2.02)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3021	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus and drug (30nM) co-administered	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.65 fraction of cell affected, shows synergism (CI = 0.21)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3022	Measles virus	wild type	RNA	Paramyxoviridae	None	No	CPT (50nM) drug administered first and then virus	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.37 fraction of cell affected, shows antagonism (CI = 1.2)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3023	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus added first and then drug CPT drug administered (50nM)	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.13 fraction of cell affected, shows antagonism (CI = 5.12)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3024	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus and drug (50nM) co-administered	No	University of toronto, canada	Human breast adenocarcinoma	MCF-7	1.0E+4 cells per well	NA	Chou-talay method	0.1 MOI	0.69 fraction of cell affected, shows synergism (CI = 0.31)	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3025	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.01 MOI	100% cell survival after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3026	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.05 MOI	100% cell survival after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3027	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	90% cell survival after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3028	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.5 MOI	90% cell survival after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3029	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	1 MOI	90% cell survival after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3030	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	3 MOI	75% cell survival after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3031	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	10 MOI	60% cell survival after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3032	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.01 MOI	100% cell survival after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3033	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.05 MOI	100% cell survival after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3034	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	75% cell survival after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3035	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.5 MOI	75% cell survival after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3036	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	1 MOI	60% cell survival after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3037	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	3 MOI	60% cell survival after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3038	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	10 MOI	40% cell survival after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3039	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus in combination with CPT (10nM)	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	80% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3040	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus in combination with CPT (30nM)	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	75% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3041	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus in combination with CPT (50nM)	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	70% cell viability after 72 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3042	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus in combination with CPT (10nM)	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	55% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3043	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus in combination with CPT (30nM)	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	48% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3044	Measles virus	wild type	RNA	Paramyxoviridae	None	No	Virus in combination with CPT (50nM)	No	Dalhousie university, canada	Human breast adenocarcinoma cell line	T-47D	1.0E+4 cells per well	NA	MTT assay	0.1 MOI	30% cell viability after 120 hours	No	No	NA	No response	NA	Induction of apoptosis	NA	NA	31043633
OV_3619	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	5000 cells per well	NA	MTT assay	1 MOI	60% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3620	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	5000 cells per well	NA	MTT assay	1 MOI	20% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3621	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	60% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3622	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	20% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3623	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human liver cancer cell line	HepG2	5000 cells per well	NA	MTT assay	1 MOI	60% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3624	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human liver cancer cell line	HepG2	5000 cells per well	NA	MTT assay	1 MOI	20% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3625	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human liver cancer cell line	Huh-4	5000 cells per well	NA	MTT assay	1 MOI	60% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3626	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human liver cancer cell line	Huh-4	5000 cells per well	NA	MTT assay	1 MOI	10% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3627	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human gastric cancer cell line	KATO III	5000 cells per well	NA	MTT assay	1 MOI	90% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3628	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human gastric cancer cell line	KATO III	5000 cells per well	NA	MTT assay	1 MOI	60% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3629	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human lung cancer cell line	H358	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3630	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human lung cancer cell line	H358	5000 cells per well	NA	MTT assay	1 MOI	30% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3631	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human lung cancer cell line	H-1299	5000 cells per well	NA	MTT assay	1 MOI	30% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3632	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human lung cancer cell line	H-1299	5000 cells per well	NA	MTT assay	1 MOI	5% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3661	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	HeLa	5000 cells per well	NA	MTT assay	1 MOI	75% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3662	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	HeLa	5000 cells per well	NA	MTT assay	1 MOI	68% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3663	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	SIHA	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3664	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human cervix cancer cell line	SIHA	5000 cells per well	NA	MTT assay	1 MOI	15% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3665	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human nasopharyngeal cell line	HK-1	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3666	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human nasopharyngeal cell line	HK-1	5000 cells per well	NA	MTT assay	1 MOI	5% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3667	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human nasopharyngeal cell line	HONE-1	5000 cells per well	NA	MTT assay	1 MOI	30% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3668	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human nasopharyngeal cell line	HONE-1	5000 cells per well	NA	MTT assay	1 MOI	20% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3669	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human eosopahgeal cancer cell line	EC109	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3670	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human eosopahgeal cancer cell line	EC109	5000 cells per well	NA	MTT assay	1 MOI	60% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3671	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human eosopahgeal cancer cell line	KYSE 70	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3672	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human eosopahgeal cancer cell line	KYSE 70	5000 cells per well	NA	MTT assay	1 MOI	25% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3673	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human colon cancer cell line	HT-29	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3674	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human colon cancer cell line	HT-29	5000 cells per well	NA	MTT assay	1 MOI	10% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3675	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human colon cancer cell line	HCT-116	5000 cells per well	NA	MTT assay	1 MOI	80% cell viability after day 3	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_3676	Measles virus	wild type	RNA	Paramyxoviridae	None	Yes	No	No	ATCC	Human colon cancer cell line	HCT-116	5000 cells per well	NA	MTT assay	1 MOI	70% cell viability after day 6	No	No	NA	No response	NA	Virus in combination with induce apiptosis in cancer cell	NA	NA	29485292
OV_4150	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	100% cell viability after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4151	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	60% cell viability after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4152	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	60% cell viability after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4153	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	25% cell viability after 6 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4154	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	10% cell viability after 7 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4155	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	100% cell viability after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4156	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	40% cell viability after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4157	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	30% cell viability after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4158	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	10% cell viability after 6 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4159	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	Yes	No	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	1 MOI	100% cell killing after 7 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4160	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 2 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	100% cell viability after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4161	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 2 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	60% cell viability after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4162	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 2 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	50% cell viability after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4163	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 2 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	5% cell viability after 6 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026
OV_4164	Measles virus	MV-s-NAP	RNA	Paramyxoviridae	Genetically engineered for expressing H.pylori neutophil activating protein	No	Virus in combination with Alisertib (70nM) before 2 hours of MV infection	No	ATCC	Human breast cancer cell line	MCF-7	5000 cells per well	NA	MTT assay	0.1 MOI	100% cell killing after 7 days	No	No	NA	No response	NA	Virus induce apoptosis process leads to cancer cell death	Virus and drug both cause induction of IL-24 expression	In clinical trials	26272026